The immunotherapy drug nivolumab (Opdivo) has been made available for some people in England with oesophageal cancer, in what has been described as a ‘step change’ for people with this cancer.
Elaine Whelan has pledged 10% of her estate to help fuel the research of tomorrow. Here, she tells us why she chose to support our work with a significant gift in her Will.
Since the 1970s, 30,000 deaths have been avoided thanks in part to the progress we’ve made in diagnosing and treating children’s and young people’s cancers.
How can we make the vital journey from research to clinical impact more efficient? It all comes down to empowering researchers to develop an entrepreneurial mindset
Pembrolizumab will be made available for some adults in Scotland with bowel cancer that’s spread to other parts of the body.
The Medicines and Healthcare products Regulatory Agency has approved the first-of-its-kind drug sotorasib for some people with non small cell lung cancer.
Dr Sally George tells us about her work on neuroblastoma and why childhood cancers really do need specific research to develop the most effective treatments.
The charity’s commercial arm saw the amount of money from both internal and external sources invested in its spinouts more than double in the last year.
The spin out companies are engineering viruses to seek and destroy cancer cells and using bacteria to break down the physical defences of tumours.